Skip to content
Mental-health — Science — Aging — Chronic-diseases — Neuroscience — Neuroscience news — Nutrition — Fitness-and-exercise — Medical-conditions

HIV Medications May Reduce Chances of Alzheimer's Disease

Approved HIV medications directed towards reverse transcriptase (RT) could potentially lower the risk of Alzheimer's disease by inhibiting comparable enzymatic functions in the aging brain.

,   and  Administrator
3 min read
HIV medications, endorsed by the FDA and focused on reverse transcriptase (RT), could potentially...
HIV medications, endorsed by the FDA and focused on reverse transcriptase (RT), could potentially lessen the risk of Alzheimer's disease. This is due to their ability to inhibit similar enzymatic actions in the aging brain.

HIV Medications May Reduce Chances of Alzheimer's Disease

Alzheimer's: A New Spin on HIV Meds for Treatment

Got Alzheimer's on your mind? You're not alone - it's the most common cause of dementia and affects over a tenth of Americans aged 65 and up. With cases in the U.S. projected to double by 2050, scientists are on the hunt for new therapies to combat this debilitating condition.

Enter HIV drugs, typically used to block a nasty enzyme called reverse transcriptase (RT). Recent research has uncovered intriguing links between common HIV drugs and reduced Alzheimer's risk.

Now, why should you care about an HIV enzyme in connection with Alzheimer's? Well, RT plays a key role in copying RNA into DNA. In the context of Alzheimer's, scientists at the Sanford Burnham Prebys institute discovered unexpected RT activity in neurons - especially those found in aging and Alzheimer's-affected brains. So, what gives?

To find more about these real-world associations, researchers dove into brain tissue samples, discovering RT enzymatic activity and novel RNAs that carry the blueprint for brain RTs, particularly in the aging human brain. This groundbreaking discovery was published in The Journal of Neuroscience.

So, where did this RT activity come from, and which brain cells are involved? Investigators zeroed in on long interspersed nuclear element-1 (LINE1), an ancient genetic sequence that makes up nearly one-fifth of all human DNA. Though usually inactive, rare forms of LINE1 have been found to harness their own RTs to copy and paste themselves elsewhere in the genome. The researchers uncovered abbreviated versions of LINE1 and found that most of these variations contained only one of the two essential protein-coding regions within a full-length transcript. Remarkably, these shortened sequences exhibited the capacity to encode RT activity.

RT activity, it turns out, was up to four times higher in gray matter, where neurons reside. Given the proven safety of FDA-approved RT inhibitor drugs, scientists believe that clinical trials studying these drugs' effects on persons with early Alzheimer's disease could serve as a near-term approach in offering hope to Alzheimer's patients and their families.

So, what's the takeaway here? Common HIV drugs, approved to block RT, may help in the fight against Alzheimer's disease. Scientists, however, are still unraveling the intricate details of this connection and will need more research to confirm the full therapeutic potential. Still, this is an exciting development in the world of neurology and a beacon of hope for those battling Alzheimer's.

Enrichment Data:

Why is there RT activity in aging and Alzheimer's-affected brains? Researchers found that this activity is associated with LINE1 elements, an ancient genetic sequence that can replicate through RT[1][2]. By blocking RT with FDA-approved HIV RT inhibitors, these drugs may prevent the accumulation of LINE1 elements, contributing to the observed reduced risk of Alzheimer's[1][2].

  1. Neuroscience news suggests a potential new approach for Alzheimer's treatment, using HIV drugs typically employed to block reverse transcriptase (RT).
  2. The association of HIV drugs with reduced Alzheimer's risk is intriguing, given that RT plays a key role in copying RNA into DNA.
  3. As cases of Alzheimer's are projected to double by 2050, seizinists are exploring novel therapies like these drugs for combating the disease.
  4. The investigation of brain tissue samples revealed RT enzymatic activity and novel RNAs associated with brain RTs in aging human brains.
  5. Research indicates that long interspersed nuclear element-1 (LINE1), a significant component of human DNA, may be responsible for the increased RT activity observed in aging and Alzheimer's-affected brains.
  6. By blocking RT with FDA-approved HIV RT inhibitors, these drugs may prevent the accumulation of LINE1 elements, potentially contributing to the reduced risk of Alzheimer's.
  7. The hunting for mental health solutions and finding ways to manage chronic diseases like Alzheimer's is an essential aspect of health-and-wellness, fitness-and-exercise, and overall neurological-disorders research. Adequate nutrition also plays a crucial role in maintaining brain health as we age.

Read also:

    Related

    Latest